{"id":"https://openalex.org/W2113230118","doi":"https://doi.org/10.1158/1535-7163.mct-05-0235","title":"Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy","display_name":"Flavopiridol disrupts STAT3/DNA interactions, attenuates STAT3-directed transcription, and combines with the Jak kinase inhibitor AG490 to achieve cytotoxic synergy","alternate_titles":[],"publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2113230118","doi":"https://doi.org/10.1158/1535-7163.mct-05-0235","mag":"2113230118","pmid":"https://pubmed.ncbi.nlm.nih.gov/16432172"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-05-0235","doi":"https://doi.org/10.1158/1535-7163.mct-05-0235","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-05-0235","pdf_url":"https://aacrjournals.org/mct/article-pdf/5/1/138/1871049/138.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2113230118"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/mct/article-pdf/5/1/138/1871049/138.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040115885","display_name":"Yean Kit Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4390039279","display_name":"Mayo Clinic Comprehensive Cancer Center (Minnesota)","ror":"https://ror.org/012wxv498","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yean Kit Lee","raw_affiliation_strings":["1Developmental Oncology Research and Divisions of","Division of Developmental Oncology Research, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Developmental Oncology Research and Divisions of","institution_ids":[]},{"raw_affiliation_string":"Division of Developmental Oncology Research, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4390039279"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046795592","display_name":"Crescent R. Isham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Crescent R. Isham","raw_affiliation_strings":["1Developmental Oncology Research and Divisions of","Mayo Clinic College of Medicine and Science;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Developmental Oncology Research and Divisions of","institution_ids":[]},{"raw_affiliation_string":"Mayo Clinic College of Medicine and Science;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054370710","display_name":"Scott H. Kaufmann","orcid":"https://orcid.org/0000-0002-4900-7145","observed_orcids":["https://orcid.org/0000-0002-4900-7145"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Scott H. Kaufman","raw_affiliation_strings":["1Developmental Oncology Research and Divisions of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Developmental Oncology Research and Divisions of","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073636065","display_name":"Keith Christopher Bible","orcid":"https://orcid.org/0000-0003-3042-5969","observed_orcids":["https://orcid.org/0000-0003-3042-5969"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keith C. Bible","raw_affiliation_strings":["2Medical Oncology, Mayo Graduate School of Medicine, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Medical Oncology, Mayo Graduate School of Medicine, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6769,"has_fulltext":true,"cited_by_count":64,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.89988714,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"5","issue":"1","first_page":"138","last_page":"148"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/flavopiridol","display_name":"flavopiridol","score":1.0},{"id":"https://openalex.org/keywords/stat3","display_name":"STAT3","score":0.9229999780654907},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9459999799728394},{"id":"https://openalex.org/keywords/ag490","display_name":"AG490","score":0.847000002861023},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8360000252723694},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.5659999847412109},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8849999904632568},{"id":"https://openalex.org/keywords/a549-cells","display_name":"A549 cells","score":0.8309999704360962},{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.7649999856948853}],"concepts":[{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.6677680611610413},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5547241568565369},{"id":"https://openalex.org/C179926584","wikidata":"https://www.wikidata.org/wiki/Q207714","display_name":"Transcription (linguistics)","level":2,"score":0.5129263401031494},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4796445965766907},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4280617833137512},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.41351670026779175},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.37412723898887634},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34087568521499634},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.31922563910484314},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22863435745239258},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1290978193283081},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C41895202","wikidata":"https://www.wikidata.org/wiki/Q8162","display_name":"Linguistics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009363","descriptor_name":"Neoplasm Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010750","descriptor_name":"Phosphoproteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010750","descriptor_name":"Phosphoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D012319","descriptor_name":"RNA Polymerase II","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012319","descriptor_name":"RNA Polymerase II","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014158","descriptor_name":"Transcription, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015536","descriptor_name":"Down-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020032","descriptor_name":"Tyrphostins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D050796","descriptor_name":"STAT3 Transcription Factor","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D050796","descriptor_name":"STAT3 Transcription Factor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D050796","descriptor_name":"STAT3 Transcription Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053613","descriptor_name":"Janus Kinase 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064549","descriptor_name":"Myeloid Cell Leukemia Sequence 1 Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.mct-05-0235","doi":"https://doi.org/10.1158/1535-7163.mct-05-0235","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-05-0235","pdf_url":"https://aacrjournals.org/mct/article-pdf/5/1/138/1871049/138.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:16432172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16432172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-05-0235","doi":"https://doi.org/10.1158/1535-7163.mct-05-0235","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-05-0235","pdf_url":"https://aacrjournals.org/mct/article-pdf/5/1/138/1871049/138.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6831343404","display_name":"Flavopiridol Targets Transcription Factor/DNA Complexes","funder_award_id":"R01CA097129","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6912916513","display_name":null,"funder_award_id":"STAT3","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2113230118.pdf","grobid_xml":"https://content.openalex.org/works/W2113230118.grobid-xml"},"referenced_works_count":57,"referenced_works":["https://openalex.org/W286443710","https://openalex.org/W1211118294","https://openalex.org/W1527674890","https://openalex.org/W1527712367","https://openalex.org/W1576380556","https://openalex.org/W1591540697","https://openalex.org/W1599861993","https://openalex.org/W1664986701","https://openalex.org/W1831621090","https://openalex.org/W1892085233","https://openalex.org/W1968847718","https://openalex.org/W1977681992","https://openalex.org/W2004942643","https://openalex.org/W2006379003","https://openalex.org/W2008993032","https://openalex.org/W2016116775","https://openalex.org/W2016548691","https://openalex.org/W2022215206","https://openalex.org/W2023375233","https://openalex.org/W2024282024","https://openalex.org/W2030245411","https://openalex.org/W2031929368","https://openalex.org/W2041204531","https://openalex.org/W2043188148","https://openalex.org/W2058314877","https://openalex.org/W2058347762","https://openalex.org/W2066408263","https://openalex.org/W2069295237","https://openalex.org/W2072493113","https://openalex.org/W2074920283","https://openalex.org/W2078818685","https://openalex.org/W2081567150","https://openalex.org/W2086056059","https://openalex.org/W2093953283","https://openalex.org/W2097306972","https://openalex.org/W2097981550","https://openalex.org/W2101528503","https://openalex.org/W2107020701","https://openalex.org/W2108514976","https://openalex.org/W2109458089","https://openalex.org/W2115276278","https://openalex.org/W2118310862","https://openalex.org/W2131549312","https://openalex.org/W2135487116","https://openalex.org/W2147347134","https://openalex.org/W2148810752","https://openalex.org/W2150439521","https://openalex.org/W2159730182","https://openalex.org/W2164277308","https://openalex.org/W2170605678","https://openalex.org/W2208707498","https://openalex.org/W2320257314","https://openalex.org/W2322090980","https://openalex.org/W2323400003","https://openalex.org/W2330829715","https://openalex.org/W2410361929","https://openalex.org/W3171360514"],"related_works":["https://openalex.org/W2119467381","https://openalex.org/W1990287990","https://openalex.org/W2090854611","https://openalex.org/W2147840403","https://openalex.org/W2090998306","https://openalex.org/W2103269725","https://openalex.org/W2365063363","https://openalex.org/W1960237217","https://openalex.org/W1483995411","https://openalex.org/W2131549312"],"abstract_inverted_index":{"Up-regulated":[0],"signal":[1],"transducers":[2],"and":[3,21,56,82,93,101,109,153,167,179,194,239,253],"activators":[4],"of":[5,16,19,26,42,120,137,248,256],"transcription":[6,174,234],"(STAT)-mediated":[7],"signaling":[8,28,258],"is":[9],"believed":[10],"to":[11,13,39,54,58,98,116,122,133,139,147,158,213],"contribute":[12],"the":[14,40,48,70,88,118,135,182,189,200,208,246],"pathogenesis":[15],"a":[17,34,110,236],"variety":[18],"solid":[20],"hematologic":[22],"cancers.":[23,43],"Consequently,":[24],"inhibition":[25],"STAT-mediated":[27],"has":[29],"recently":[30],"been":[31],"proposed":[32],"as":[33],"potential":[35],"new":[36],"therapeutic":[37],"approach":[38],"treatment":[41],"Having":[44],"shown":[45],"previously":[46],"that":[47,63,72,229],"pan-cyclin-dependent":[49],"kinase":[50],"inhibitor":[51,202,211],"flavopiridol":[52,73,121,138,152,230,252],"binds":[53],"DNA":[55,105],"seems":[57],"kill":[59],"cancer":[60,223],"cells":[61],"via":[62],"process":[64],"in":[65,217,235,245],"some":[66],"circumstances,":[67],"we":[68],"evaluated":[69],"hypothesis":[71],"might":[74],"consequently":[75],"disrupt":[76,123,160],"STAT3/DNA":[77,124,161],"interactions,":[78],"attenuate":[79,140,172,232],"STAT3-directed":[80,141,173,233],"transcription,":[81],"down-regulate":[83,181],"STAT3":[84,127,183,209,257],"downstream":[85,184],"polypeptides,":[86],"including":[87],"antiapoptotic":[89,185],"polypeptide":[90,102,186],"Mcl-1.":[91],"SDS-PAGE/immunoblotting":[92],"reverse":[94],"transcription-PCR":[95,193],"were":[96,114,145],"used":[97,115,132,146],"assess":[99,148],"RNA":[100],"levels,":[103],"respectively.":[104],"cellulose":[106,164],"affinity":[107,165],"chromatography":[108,166],"nuclear":[111,168],"elution":[112,169],"assay":[113,130],"evaluate":[117],"ability":[119,136],"interactions.":[125],"A":[126],"luciferase":[128,176],"reporter":[129,177],"was":[131,156],"examine":[134],"transcription.":[142],"Colony-forming":[143],"assays":[144],"cytotoxic":[149,215],"synergy":[150,216],"between":[151],"AG490.":[154],"Flavopiridol":[155],"found":[157],"(a)":[159],"interactions":[162],"(DNA":[163],"assay),":[170,178],"(b)":[171],"(STAT3":[175],"(c)":[180],"Mcl-1":[187],"at":[188],"transcriptional":[190],"level":[191],"(reverse":[192],"SDS-PAGE/immunoblotting).":[195],"Furthermore,":[196],"flavopiridol,":[197],"but":[198],"not":[199],"microtubule":[201],"paclitaxel,":[203],"could":[204],"be":[205,242],"combined":[206],"with":[207],"pathway":[210],"AG490":[212],"achieve":[214],"A549":[218],"human":[219],"non-small":[220],"cell":[221],"lung":[222],"cells.":[224],"Collectively,":[225],"these":[226],"data":[227],"suggest":[228],"can":[231],"targeted":[237],"fashion":[238],"may":[240],"therefore":[241],"exploitable":[243],"clinically":[244],"development":[247],"chemotherapy":[249],"regimens":[250],"combining":[251],"other":[254],"inhibitors":[255],"pathways.":[259]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2113230118","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
